Scientists collect chest tumor samples to unlock secrets of cancer spread
NCT ID NCT04844827
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collected tissue and blood samples from 143 people with malignant pleural effusion (cancer that has spread to the lining of the chest). The goal was to create a biobank for future research into why cancer cells in the chest may differ from the original tumor. No treatment was given; the focus was on gathering samples for later analysis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this biobank could help researchers understand why cancer cells in the chest lining differ from the original tumor, potentially pointing toward better treatments.
- What could go wrong
- This is a tissue-collection study, not a treatment trial. It does not test any therapy, and any future benefits depend on many years of additional research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLEURAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Louis Pradel Hospital
Bron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- New PET tracer could spot cancers that standard scans overlook
- Catheter study finds symptom relief for fluid buildup
- Scientists use patients' own lung fluid cells to fight advanced cancer
- New biomarker may predict which cancer drugs work best
- Could tiny chest tubes make fluid drainage less painful?